NeoGenomics
Receive regular headline summaries whenever high-quality news is generated for NeoGenomics. We'll never share your email address with others.
Selected Headlines
| Date | Headline (link) | Source | Relevant Snippet |
|---|---|---|---|
| 10/16/2021 | NeoGenomics (NASDAQ:NEO) Shares Gap Up to $42.00 - Mayfield Recorder | Mayfield Recorder | NeoGenomics, Inc. (NASDAQ:NEO)’s share price gapped up before the market opened on Thursday . The stock had previously closed at $42.00, but opened at $43.71. NeoGenomics shares last traded at $43.94, with a volume of 1,215 shares.Several equities analysts recently commented on the company. Morgan Stanley reduced their price target on NeoGenomics from $64.00 to $58.00 and set an “overweight” rating on the stock in a research ... |
| 10/16/2021 | Raymond James Upgrades NeoGenomics (NASDAQ:NEO) to Outperform | dispatchtribunal.com | ... of 22.18% from the stock’s previous close. Other analysts also recently issued reports about the stock. Needham & Company LLC reissued a “buy” rating and issued a $55.00 price target on shares of NeoGenomics in a research note on Monday, August 9th. Zacks Investment Research raised shares of NeoGenomics from a “sell” rating to a “hold” rating in a research note on Tuesday, August 17th. Benchmark boosted ... |
| 10/16/2021 | NeoGenomics (NASDAQ:NEO) Raised to “Outperform” at Raymond James | theenterpriseleader.com | ... from the stock’s current price. NEO has been the subject of a number of other reports. Needham & Company LLC reissued a “buy” rating and issued a $55.00 price objective on shares of NeoGenomics in a research note on Monday, August 9th. Benchmark raised their target price on shares of NeoGenomics from $46.00 to $50.00 and gave the company a “buy” rating in a research note on Thursday ... |
| 10/16/2021 | Zacks: Brokerages Expect NeoGenomics, Inc. (NASDAQ:NEO) Will Announce Earnings of -$0.08 Per Share | baseballnewssource.com | Wall Street analysts expect that NeoGenomics, Inc. (NASDAQ:NEO) will report earnings of ($0.08) per share for the current fiscal quarter, according to Zacks . Three analysts have issued estimates for NeoGenomics’ earnings. The highest EPS estimate is ($0.05) and the lowest is ($0.10). NeoGenomics reported earnings per share of $0.06 in the same quarter last year, which suggests a negative year-over-year growth rate of 233.3%. The company ... |
| 10/16/2021 | Analysts Anticipate NeoGenomics, Inc. (NASDAQ:NEO) Will Announce Earnings of -$0.08 Per Share | dispatchtribunal.com | Equities analysts forecast that NeoGenomics, Inc. (NASDAQ:NEO) will report earnings of ($0.08) per share for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for NeoGenomics’ earnings, with the lowest EPS estimate coming in at ($0.10) and the highest estimate coming in at ($0.05). NeoGenomics posted earnings per share of $0.06 during the same quarter last year, which would suggest a negative year-over-year growth ... |
| 10/15/2021 | NeoGenomics, Inc. (NASDAQ:NEO) Given Average Rating of “Buy” by Analysts | com-unik.info | ... that have updated their coverage on the stock in the last year is $52.83. A number of equities analysts have recently issued reports on NEO shares. Benchmark upped their target price on shares of NeoGenomics from $46.00 to $50.00 and gave the stock a “buy” rating in a research report on Thursday, August 26th. Needham & Company LLC reiterated a “buy” rating and set a $55.00 target price on ... |
| 10/15/2021 | NeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Recommendation of “Buy” from Analysts | thelincolnianonline.com | ... covered the stock in the last year is $52.83. Several analysts recently weighed in on the stock. Needham & Company LLC reiterated a “buy” rating and issued a $55.00 price target on shares of NeoGenomics in a report on Monday, August 9th. Morgan Stanley lowered their price objective on NeoGenomics from $64.00 to $58.00 and set an “overweight” rating for the company in a research report on Monday, August ... |
| 10/15/2021 | Gulfshore Business Daily: Oct. 15 | gulfshorebusiness.com | Lead Photo: Seagate completes NeoGenomics ’ global headquarters. Details below.COLLIER COUNTY COMMISSIONERS DECLINE PLAN FOR FOOD TRUCK PARK IN ISLE OF CAPRICollier County commissioners, acting as the Board of Zoning Appeals this week, unanimously overturned a staff recommendation that would have allowed a proposed food truck park to be built on Isles of Capri. The proposed local development on more than 2 acres of land zoned C-3 ... |
| 10/15/2021 | NeoGenomics – Consensus Indicates Potential 34.4% Upside | directorstalkinterviews.com | ... with Inivata Limited; and has collaboration with Elevation Oncology to expand genomic testing for NRG1 fusions across solid tumors. The company was founded in 2001 and is headquartered in Fort Myers, Florida.This article NeoGenomics – Consensus Indicates Potential 34.4% Upside first appeared on DirectorsTalk Interviews ... |
| 10/15/2021 | Ensign Peak Advisors Inc Grows Position in NeoGenomics, Inc. (NASDAQ:NEO) | American Banking News | Ensign Peak Advisors Inc boosted its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO) by 19.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 103,000 shares of the medical research company’s stock after purchasing an additional 16,800 shares during the period. Ensign Peak Advisors Inc owned approximately 0.08% of NeoGenomics worth $4,653,000 at the end ... |
| 10/15/2021 | Ensign Peak Advisors Inc Grows Position in NeoGenomics, Inc. (NASDAQ:NEO) | Dakota Financial News | Ensign Peak Advisors Inc boosted its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO) by 19.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 103,000 shares of the medical research company’s stock after purchasing an additional 16,800 shares during the period. Ensign Peak Advisors Inc owned approximately 0.08% of NeoGenomics worth $4,653,000 at the end ... |
| 10/15/2021 | NeoGenomics (NASDAQ:NEO) Upgraded to Outperform at Raymond James | baseballnewssource.com | Raymond James upgraded shares of NeoGenomics (NASDAQ:NEO) from a market perform rating to an outperform rating in a report issued on Thursday morning, Price Targets.com reports. Raymond James currently has $53.00 price objective on the medical research company’s stock.Several other brokerages have also recently issued reports on NEO. Benchmark raised their price objective on NeoGenomics from $46.00 to $50.00 and gave the stock a buy rating in ... |
| 10/15/2021 | NeoGenomics (NASDAQ:NEO) Upgraded to Outperform at Raymond James - The Cerbat Gem | thecerbatgem.com | Raymond James upgraded shares of NeoGenomics (NASDAQ:NEO) from a market perform rating to an outperform rating in a research report released on Thursday, Price Targets.com reports. Raymond James currently has $53.00 target price on the medical research company’s stock.A number of other brokerages have also recently weighed in on NEO. Morgan Stanley dropped their price objective on shares of NeoGenomics from $64.00 to $58.00 and set an ... |
| 10/15/2021 | American Capital Management Inc. Has $10.69 Million Stake in NeoGenomics, Inc. (NASDAQ:NEO) | slatersentinel.com | American Capital Management Inc. increased its position in NeoGenomics, Inc. (NASDAQ:NEO) by 0.7% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 236,591 shares of the medical research company’s stock after purchasing an additional 1,723 shares during the period. American Capital Management Inc.’s holdings in NeoGenomics were worth $10,687,000 at the end of the most recent reporting period. A ... |
| 10/15/2021 | American Capital Management Inc. Increases Holdings in NeoGenomics, Inc. (NASDAQ:NEO) - Mayfield Recorder | Mayfield Recorder | American Capital Management Inc. increased its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO) by 0.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 236,591 shares of the medical research company’s stock after purchasing an additional 1,723 shares during the period. American Capital Management Inc. owned 0.19% of NeoGenomics worth $10,687,000 as of its most recent ... |
| 10/14/2021 | NeoGenomics Schedules its Third Quarter 2021, Earnings Release for November 4, 2021 | portlandnews.net | FT. MYERS, FL / ACCESSWIRE / October 13, 2021 / NeoGenomics , Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to release its third quarter 2021, financial results on Thursday, November 4, 2021.The Company has scheduled a webcast and conference call to discuss their third quarter results on Thursday, November 4, 2021 at 8:30 AM EDT. Interested investors should dial ... |
| 10/14/2021 | NeoGenomics Schedules its Third Quarter 2021, Earnings Release for November 4, 2021 | illinoisintelligencer.com | FT. MYERS, FL / ACCESSWIRE / October 13, 2021 / NeoGenomics , Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to release its third quarter 2021, financial results on Thursday, November 4, 2021.The Company has scheduled a webcast and conference call to discuss their third quarter results on Thursday, November 4, 2021 at 8:30 AM EDT. Interested investors should dial ... |
| 10/14/2021 | The Ridgway Record | ridgwayrecord.com | FT. MYERS, FL NeoGenomics , Inc. ( NASDAQ:NEO ), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to release its third quarter 2021, financial results on Thursday, November 4, 2021.The Company has scheduled a webcast and conference call to discuss their third quarter results on Thursday, November 4, 2021 at 8:30 AM EDT. Interested investors should dial (888) 506-0062 (domestic) and ... |
| 10/14/2021 | NeoGenomics (NASDAQ:NEO) Lifted to ‚ÄúOutperform‚Äù at Raymond James | American Banking News | ... Äúmarket perform‚Äù rating to an ‚Äúoutperform‚Äù rating in a research report issued on Thursday, The Fly reports.Other research analysts also recently issued research reports about the company. Zacks Investment Research upgraded NeoGenomics from a ‚Äúsell‚Äù rating to a ‚Äúhold‚Äù rating in a research note on Tuesday, August 17th. Benchmark raised their target price on NeoGenomics from $46.00 to $50.00 and gave the stock a ‚Äúbuy ... |
| 10/14/2021 | Upgrades and Downgrades for Thursday, 10/14 | tradesoftheday.com | ... Overweight - National Vision (EYE) upgraded by Morgan Stanley from Equal Weight to Overweight - Wipro (WIT) upgraded by Morgan Stanley from Underweight to Equal Weight - Chemtrade Logistics (CGIFF) upgraded by Desjardins from Hold to Buy - NeoGenomics (NEO) upgraded by Raymond James from Market Perform to Outperform - Bank of Queensland (BKQNY) upgraded by Citi from Neutral to Buy - Chorus (CHRYY) upgraded by UBS from Sell to Neutral - Pipestone Energy (BKBEF) upgraded by ... |